Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Delabesse

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Leukemia|November 13, 2009
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemiaE Chapiro, L Russell, E Lainey, et al.
Leukemia|February 28, 2013
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemiasF Damm, R Itzykson, O Kosmider, et al.
Leukemia|October 17, 2003
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer programE Beillard, N Pallisgaard, V H J van der Velden, et al.
Leukemia|December 22, 1999
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaJ J van Dongen, E A Macintyre, J A Gabert, et al.
Leukemia|April 20, 2012
RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiationP Ballerini, S Struski, C Cresson, et al.
Leukemia|April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective studyF Lefrère, A Delmer, F Suzan, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Leukemia|July 14, 2006
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 studyA Delannoy, E Delabesse, V Lhéritier, et al.
Leukemia|October 4, 2016
NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosisS Struski, S Lagarde, P Bories, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|November 13, 2009
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemiaE Chapiro, L Russell, E Lainey, et al.
Leukemia|February 28, 2013
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemiasF Damm, R Itzykson, O Kosmider, et al.
Leukemia|October 17, 2003
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer programE Beillard, N Pallisgaard, V H J van der Velden, et al.
Leukemia|December 22, 1999
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaJ J van Dongen, E A Macintyre, J A Gabert, et al.
Leukemia|April 20, 2012
RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiationP Ballerini, S Struski, C Cresson, et al.
Leukemia|April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective studyF Lefrère, A Delmer, F Suzan, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Leukemia|July 14, 2006
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 studyA Delannoy, E Delabesse, V Lhéritier, et al.
Leukemia|October 4, 2016
NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosisS Struski, S Lagarde, P Bories, et al.
Leukemia|October 17, 2012
Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALLR Garand, K Beldjord, H Cavé, et al.
Pageof 6